Takeda Pharmaceutical Co. (TAK)
(Delayed Data from NYSE)
$13.36 USD
-0.13 (-0.96%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $13.35 -0.01 (-0.07%) 7:58 PM ET
5-Strong Sell of 5 5
A Value D Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO7/31/24 |
---|---|
Current Quarter | 0.37 |
EPS Last Quarter | 0.00 |
Last EPS Surprise | NA |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 1.29 |
Next Year | 1.42 |
EPS (TTM) | 1.56 |
P/E (F1) | 10.36 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 25.61B | 26.64B |
# of Estimates | NA | NA | 1 | 2 |
High Estimate | NA | NA | 25.61B | 27.81B |
Low Estimate | NA | NA | 25.61B | 25.47B |
Year ago Sales | 7.71B | 6.94B | 27.57B | 25.61B |
Year over Year Growth Est. | NA | NA | -7.12% | 4.03% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.37 | NA | 1.29 | 1.42 |
# of Estimates | 1 | NA | 2 | 2 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 0.37 | NA | 1.45 | 1.64 |
Low Estimate | 0.37 | NA | 1.13 | 1.20 |
Year ago EPS | 0.55 | 0.50 | 1.67 | 1.29 |
Year over Year Growth Est. | -32.73% | NA | -22.75% | 10.08% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | NA | 1 | 0 |
Up Last 30 Days | 0 | NA | 1 | 0 |
Up Last 60 Days | 0 | NA | 0 | 0 |
Down Last 7 Days | 1 | NA | 0 | 1 |
Down Last 30 Days | 1 | NA | 0 | 1 |
Down Last 60 Days | 0 | NA | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Current | 0.37 | NA | 1.29 | 1.42 |
7 Days Ago | 0.42 | NA | 1.27 | 1.43 |
30 Days Ago | 0.42 | NA | 1.27 | 1.43 |
60 Days Ago | NA | NA | 1.55 | 1.40 |
90 Days Ago | NA | NA | 1.55 | 1.40 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.37 | NA | 1.45 | 1.64 |
Zacks Consensus Estimate | 0.37 | NA | 1.29 | 1.42 |
Earnings ESP | 0.00% | NA | 12.40% | 15.49% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.00 | 0.51 | 0.50 | 0.55 | NA |
Estimate | NA | NA | NA | NA | NA |
Difference | NA | NA | NA | NA | NA |
Surprise | NA | NA | NA | NA | NA |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more